The role of our center is to identify the greatest number of people who have prediabetes and... put them on the road to healing.
King of Prussia, PA (PRWEB) May 22, 2013
The PreDiabetes Center of King of Prussia is proud to announce its participation in the Greater Philadelphia Tour de Cure, a premier cycling event that brings together experienced cyclists and recreational riders who are passionate about stopping the spread of diabetes, a chronic disease that affects more than 25 million Americans.
The Tour de Cure will take place Saturday, June 1 at Temple Ambler Campus, located at 580 Meetinghouse Road in Ambler, 30 minutes outside of Philadelphia, between the hours of 7:30 a.m. and 4 p.m.
Cyclists will ride in one of three routes throughout Bucks and Montgomery counties. Rider-friendly food and beverages will be provided to cyclists at themed rest stops. The Philly Tour de Cure will host a celebration at the finish line, stocked high with delicious food, entertainment and a health and fitness festival. People interested in cycling in the ride can register at the event for a $25 fee. Those who are not cycling in the event are encouraged to bring friends and family and enjoy festivities at the finish line.
PreDiabetes Centers is excited to take part in the event. The Company will be conducting free diabetes-risk assessments and will have staff on hand to speak about the dangers of prediabetes and also schedule free blood screenings for people who feel they may be at risk.
Those who are unable to attend the event can book a free blood screening by calling 1-855-399-7733 (PRED). For greater convenience, people also have the option of scheduling online.
Dr. Andre Garabedian, a prediabetes physician at the PreDiabetes Center of King of Prussia, believes it’s important that people understand their individual risk for type 2 diabetes.
Dr. Garabedian is a prominent physician specializing in chronic disorders, and has practiced family medicine in the King of Prussia area for more than 30 years. He meets with clients at the PreDiabetes Center of King of Prussia, located at 491 Allendale Road, Suite 222.
Years before people are diagnosed with diabetes, damage is already occurring in their body when they have prediabetes, defined as blood glucose levels that are high but not yet high enough for a diabetes diagnosis. More than 79 million Americans have prediabetes, and many are unaware of their condition because the symptoms are often invisible.
Fortunately, there are ways doctors can detect prediabetes before the condition progresses to type 2 diabetes.
PreDiabetes Centers offers a free blood screening that measures several biomarkers, or chemicals and proteins in the blood. Fasting blood sugar and hemoglobin A1c are important biomarkers that the Center tests, but there are many other biomarkers that can help provide more expansive insight into the multiple factors contributing to a person’s prediabetes diagnosis.
“What makes PreDiabetes Centers so unique is that we specifically treat prediabetes,” said Dr. Garabedian.
“The role of our center is to identify the greatest number of people who have prediabetes and try to address their [contributing health problems] and put them on the road to healing,” he said.
Dr. Garabedian notes that diabetes causes more damage than people might think. “It’s much more than blood sugar levels: It’s associated with remarkably complicated and extremely serious diseases, such as cardiovascular disease,” he said, which is why it’s important to catch prediabetes before it progresses to advanced stages.
People with prediabetes are likely to develop type 2 diabetes within three to 10 years. Once a person has diabetes, it increases his or her risk of stroke, kidney damage and nerve damage.
PreDiabetes Centers is a privately owned company based in Austin, Texas, dedicated to the prevention and treatment of diabetes. Treatment at the Center is based on physician-directed care and lifestyle intervention tailored for each client. The company offers a 12-month personalized program that treats prediabetes and its associated conditions, and uses advanced biomarker testing to monitor specific processes in the body associated with prediabetic conditions.